Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Reference27 articles.
1. Waddington-Cruz M, Schmidt H, Botteman MF, et al. Epidemiological and clinical characteristics of persons with transthyretin familial amyloid polyneuropathy: A global synthesis of 532 cases. In: International Society of Amyloidosis - XV International Symposium on Amyloidosis (ISA); 2016.
2. Plante-Bordeneuve V. Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy. J Neurol. 2014;261(6):1227–33.
https://doi.org/10.1007/s00415-014-7373-0
.
3. Misu KI, Hattori N, Nagamatsu M, et al. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain. 1999;122(1):1951–62.
4. Schmidt HH, Waddington-Cruz M, Botteman MF, et al. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle Nerve. 2018;57(5):829–37.
https://doi.org/10.1002/mus.26034
.
5. Yamashita T, Ando Y, Okamoto S, et al. Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy. Neurology. 2012;78(9):637–43.
https://doi.org/10.1212/WNL.0b013e318248df18
.
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献